Cited by 724PI3K/AKT/mTOR signaling in cancerTuberous Sclerosis Complex ResearchMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

A complex interplay between Akt, TSC2 and the two mTOR complexes

Open access

Huang, Jingxiang, Manning, Brendan D.·2009·Biochemical Society Transactions

Open this paper in CoChat — free account

Abstract

Akt/PKB (protein kinase B) both regulates and is regulated by the TSC (tuberous sclerosis complex) 1–TSC2 complex. Downstream of PI3K (phosphoinositide 3-kinase), Akt phosphorylates TSC2 directly on multiple sites. Although the molecular mechanism is not well understood, these phosphorylation events relieve the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1 [mTOR (mammalian target of rapamycin) complex] 1, thereby activating mTORC1 in response to growth factors. Through negative-feedback mechanisms, mTORC1 activity inhibits growth factor stimulation of PI3K. This is particularly evident in cells and tumours lacking the TSC1–TSC2 complex, where Akt signalling is severely attenuated due, at least in part, to constitutive activation of mTORC1. An additional level of complexity in the relationship between Akt and the TSC1–TSC2 complex has recently been uncovered. The growth-factor-stimulated kinase activity of mTORC2 [also known as the mTOR–rictor (rapamycin-insensitive companion of mTOR) complex], which normally enhances Akt signalling by phosphorylating its hydrophobic motif (Ser473), was found to be defective in cells lacking the TSC1–TSC2 complex. This effect on mTORC2 can be separated from the inhibitory effects of the TSC1–TSC2 complex on Rheb and mTORC1. The present review discusses our current understanding of the increasingly complex functional interactions between Akt, the TSC1–TSC2 complex and mTOR, which are fundamentally important players in a large variety of human diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1042/bst0370217

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Self-citation
TOR signaling in growth and metabolism
Wullschleger, S., Loewith, R., & Hall, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.01.016 · Cited by 5,787
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365

Show all 35 references

Sorted by citations

Items 201–300 of 723

Activating mutations of TOR (target of rapamycin)
Hardt, M. E., Chantaravisoot, N., & Tamanoi, F. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01482.x · Cited by 65
mTORC1 signaling in energy balance and metabolic disease
Catania, C., Binder, E., & Cota, D. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.208 · Cited by 68
Enhanced mTORC1 signaling and protein synthesis in pathologic α-synuclein cellular and animal models of Parkinson’s disease
Khan, M. R., Yin, X., Kang, S.-U., Mitra, J., Wang, H., Ryu, T., Brahmachari, S., Karuppagounder, S. S., Kimura, Y., Jhaldiyal, A., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add0499 · Cited by 64
The effect of adipocyte–macrophage crosstalk in obesity-related breast cancer
Engin, A. B., Engin, A., & Gönül, İ. I. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0252 · Cited by 64
Regulation of mTORC1 by amino acids in mammalian cells: A general picture of recent advances
Zhang, S., Lin, X., Hou, Q., Hu, Z., Wang, Y., & Wang, Z. (2021) · Animal nutrition · doi:10.1016/j.aninu.2021.05.003 · Cited by 68
The effects of mutant Ras proteins on the cell signalome
Takács, T., Kudlik, G., Kurilla, A., Szeder, B., Buday, L., & Vas, V. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09912-8 · Cited by 62
Ex Vivo Molecular Rejuvenation Improves the Therapeutic Activity of Senescent Human Cardiac Stem Cells in a Mouse Model of Myocardial Infarction
Avolio, E., Gianfranceschi, G., Cesselli, D., Caragnano, A., Athanasakis, E., Katare, R., Meloni, M., Palma, A., Barchiesi, A., Vascotto, C., et al. (2014) · Stem Cells · doi:10.1002/stem.1728 · Cited by 62
A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumours
Tolcher, A. W., Goldman, J., Patnaik, A., Papadopoulos, K. P., Westwood, P., Kelly, C. S., Bumgardner, W., Sams, L. L., Geeganage, S., Wang, T., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.039 · Cited by 62
Self-citation
iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions
Wu, J., Yang, J., Yang, K., Wang, H., Gorentla, B. K., Shin, J., Qiu, Y., Que, L. G., Foster, W. M., Xia, Z., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69780 · Cited by 63
Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin
Kim, S.-H., Speirs, C. K., Solnica‐Krezel, L., & Ess, K. C. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005587 · Cited by 61
Induction of autophagy and suppression of type I IFN secretion by CSFV
Xie, B., Zhao, M., Song, D., Wu, K., Yi, L., Li, W., Li, X., Wang, K., & Chen, J. (2020) · Autophagy · doi:10.1080/15548627.2020.1739445 · Cited by 61
PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review
Rajendran, P., Sekar, R., Shankar, D. P., Ali, E. M., Abdelsalam, S. A., Balaraman, S., Chellappan, B. V., Metwally, A. M., & Abdallah, B. M. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.94566 · Cited by 67
Role and mechanisms of autophagy, ferroptosis, and pyroptosis in sepsis-induced acute lung injury
Shen, Y., He, Y., Pan, Y., Liu, L., Liu, Y., & Jia, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1415145 · Cited by 66
Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
Chen, M., Lu, J., Wei, W., Lv, Y., Zhang, X., Yao, Y., Wang, L., Ling, T., & Zou, X. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s161198 · Cited by 61
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells
Brünner-Kubath, C., Shabbir, W., Saferding, V., Wagner, R., Singer, C. F., Valent, P., Berger, W., Marian, B., Zielinski, C. C., Grusch, M., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1232-1 · Cited by 61
Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12- O -Tetradecanoylphorbol-13-Acetate
Checkley, L. A., Rho, O., Moore, T., Hursting, S., & DiGiovanni, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0375 · Cited by 60
A review of fasting effects on the response of cancer to chemotherapy
Sadeghian, M., Rahmani, S., Khalesi, S., & Hejazi, E. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.10.037 · Cited by 60
Signaling crosstalk between the mTOR complexes
Xie, J., & Proud, C. G. (2014) · Translation · doi:10.4161/trla.28174 · Cited by 60
Protein Phosphatase 2A and DNA-dependent Protein Kinase Are Involved in Mediating Rapamycin-induced Akt Phosphorylation
Li, Y., Wang, X., Yue, P., Tao, H., Ramalingam, S. S., Owonikoko, T. K., Deng, X., Wang, Y., Fu, H., Khuri, F. R., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463679 · Cited by 57
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
Franco, R., Martínez‐Pinilla, E., Navarro, G., & Zamarbide, M. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.01.004 · Cited by 61
Enhancing mTOR-targeted cancer therapy
Wang, X., & Sun, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903225008 · Cited by 59
Stoichiometry and assembly of mTOR complexes revealed by single-molecule pulldown
Jain, A., Arauz, E. J., Aggarwal, V., Ikon, N., Chen, J., & Ha, T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419425111 · Cited by 59
mSIN1 Protein Mediates SGK1 Protein Interaction with mTORC2 Protein Complex and Is Required for Selective Activation of the Epithelial Sodium Channel
Lu, M., Wang, J., Ives, H. E., & Pearce, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257592 · Cited by 55
IL-15 Complexes Induce Migration of Resting Memory CD8 T Cells into Mucosal Tissues
Sowell, R., Goldufsky, J. W., Rogozinska, M., Quiles, Z., Cao, Y., Castillo, E. F., Finnegan, A., & Marzo, A. L. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1501638 · Cited by 60
Current understanding of insulin resistance in hepatitis C
Kaddai, V., & Negro, F. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.43 · Cited by 59
PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Roles for insulin-supported skeletal muscle growth1,2
Rhoads, R. P., Baumgard, L. H., El‐Kadi, S. W., & Zhao, L. D. (2016) · Journal of Animal Science · doi:10.2527/jas.2015-0110 · Cited by 56
Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations
Kfir‐Erenfeld, S., Sionov, R. V., Spokoini, R., Cohen, O., & Yefenof, E. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.506570 · Cited by 57
A Small Molecule Inhibits Akt through Direct Binding to Akt and Preventing Akt Membrane Translocation
Kim, D., Sun, M., He, L., Zhou, Q., Chen, J., Sun, X.-M., Bepler, G., Sebti, S. M., & Cheng, J. Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094060 · Cited by 55
Retracted
TRIENNIAL GROWTH SYMPOSIUM: Leucine acts as a nutrient signal to stimulate protein synthesis in neonatal pigs1,2
Suryawan, A., Orellana, R. A., Fiorotto, M. L., & Davis, T. A. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-3400 · Cited by 55
Epigenetics advancing personalized nanomedicine in cancer therapy
Liu, S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.004 · Cited by 59
Functional Roles of Arginine During the Peri-Implantation Period of Pregnancy. III. Arginine Stimulates Proliferation and Interferon Tau Production by Ovine Trophectoderm Cells via Nitric Oxide and Polyamine-TSC2-MTOR Signaling Pathways1
Wang, X., Burghardt, R. C., Romero, J. J., Hansen, T. R., Wu, G., & Bazer, F. W. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.125989 · Cited by 57
The GATOR2–mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation
Kowalsky, A. H., Namkoong, S., Mettetal, E., Park, H., Kazyken, D., Fingar, D. C., & Lee, J. H. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010857 · Cited by 57
Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway
Mencer, S., Kartawy, M., Lendenfeld, F. V., Soluh, H., Tripathi, M. K., Khaliulin, I., & Amal, H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01578-2 · Cited by 55
Jejunal Proteins Secreted by db/db Mice or Insulin-Resistant Humans Impair the Insulin Signaling and Determine Insulin Resistance
Salinari, S., Debard, C., BERTUZZI, A., Durand, C., Zimmet, P., Vidal, H., & Mingrone, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056258 · Cited by 54
The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology
Martelli, A. M., Evangelisti, C., Chiarini, F., Grimaldi, C., & McCubrey, J. A. (2010) · Cancers · doi:10.3390/cancers2031576 · Cited by 57
RETRACTED ARTICLE: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma
Li, X., Lee, Y., Kang, Y., Dai, B., Perez, M. V. R., Pratt, M. F., Koay, E. J., Kim, M. P., Brekken, R. A., & Fleming, J. B. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0207-3 · Cited by 54
Retracted
A Conserved Role of IQGAP1 in Regulating TOR Complex 1
Tekletsadik, Y. K., Sonn, R., & Osman, M. A. (2012) · Journal of Cell Science · doi:10.1242/jcs.098947 · Cited by 56
Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling
Hakim, S., Dyson, J. M., Feeney, S. J., Davies, E. M., Sriratana, A., Koenig, M. N., Plotnikova, O. V., Smyth, I., Ricardo, S. D., Hobbs, R. M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw097 · Cited by 52
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer
Mauro, L., Naimo, G. D., Gelsomino, L., Malivindi, R., Bruno, L., PELLEGRINO, M. A., Tarallo, R., Memoli, D., Weisz, A., Panno, M. L., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701315r · Cited by 54
The lysosomal GPCR-like protein GPR137B regulates Rag and mTORC1 localization and activity
Gan, L., Seki, A., Shen, K., Iyer, H., Han, K., Hayer, A., Wollman, R., Ge, X., Lin, J. R., Dey, G., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0321-6 · Cited by 53
Control of hepatic glucose metabolism by islet and brain
Rojas, J. M., & Schwartz, M. W. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12332 · Cited by 56
Therapeutic Implications of Targeting AKT Signaling in Melanoma
Madhunapantula, S. V., & Robertson, G. P. (2011) · Enzyme Research · doi:10.4061/2011/327923 · Cited by 57
Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines
Galluzzi, L., Santi, M. D., Crinelli, R., Marco, C. D., Zaffaroni, N., Duranti, A., Brandi, G., & Magnani, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043249 · Cited by 55
Pyrogallol, an absorbable microbial gallotannins-metabolite and mango polyphenols (Mangifera Indica L.) suppress breast cancer ductal carcinoma in situ proliferation in vitro
Nemec, M. J., Kim, H., Marciante, A. B., Barnes, R. C., Talcott, S. T., & Mertens‐Talcott, S. U. (2016) · Food & Function · doi:10.1039/c6fo00636a · Cited by 52
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
Uehara, K., Sostre‐Colón, J., Gavin, M. J., Santoleri, D., Leonard, K., Jacobs, R. L., & Titchenell, P. M. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.02.015 · Cited by 54
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas
Beauchamp, R. L., James, M. F., DeSouza, P., Wagh, V., Zhao, W., Jordan, J. T., Stemmer-Rachamimov, A. O., Plotkin, S. R., Gusella, J. F., Haggarty, S. J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4858 · Cited by 51
Real-time Imaging Reveals That P2Y2 and P2Y12 Receptor Agonists Are Not Chemoattractants and Macrophage Chemotaxis to Complement C5a Is Phosphatidylinositol 3-Kinase (PI3K)- and p38 Mitogen-activated Protein Kinase (MAPK)-independent
Isfort, K., Ebert, F., Bornhorst, J., Sargin, S., Kardakaris, R., Pasparakis, M., Bähler, M., Schwerdtle, T., Schwab, A., & Hanley, P. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.289793 · Cited by 51
IL-10 Function, Regulation, and in Bacterial Keratitis
Hazlett, L. D., Jiang, X., & McClellan, S. A. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2014.0018 · Cited by 54
Inhibition and Termination of Physiological Responses by GTPase Activating Proteins
Ligeti, E., Welti, S., & Scheffzek, K. (2012) · Physiological Reviews · doi:10.1152/physrev.00045.2010 · Cited by 61
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Ma, H., Liu, S., Li, S., & Xia, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.918771 · Cited by 55
Organization of the ENaC-regulatory machinery
Soundararajan, R., Lu, M., & Pearce, D. (2012) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2012.678285 · Cited by 49
Metformin Inhibits Androgen-Induced IGF-IR Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen Signaling
Malaguarnera, R., Sacco, A., Morcavallo, A., Squatrito, S., Migliaccio, A., Morrione, A., Maggiolini, M., & Belfiore, A. (2014) · Endocrinology · doi:10.1210/en.2013-1925 · Cited by 50
Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1)
Sánchez, I., Balagué, E., & Matilla‐Dueñas, A. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw242 · Cited by 50
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy?
Lamberti, G., Brighi, N., Maggio, I., Manuzzi, L., Peterle, C., Ambrosini, V., Ricci, C., Casadei, R., & Campana, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030747 · Cited by 51
Neural progenitors derived from Tuberous Sclerosis Complex patients exhibit attenuated PI3K/AKT signaling and delayed neuronal differentiation
Zucco, A. J., Pozzo, V. D., Afinogenova, A., Hart, R. P., Devinsky, O., & D’Arcangelo, G. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.08.004 · Cited by 48
Insulin like growth factor‐1‐induced phosphorylation and altered distribution of tuberous sclerosis complex (TSC)1/TSC2 in C2C12 myotubes
Miyazaki, M., McCarthy, J. J., & Esser, K. A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07635.x · Cited by 50
The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.
Schult, C., Dahlhaus, M., Glass, Ä., Fischer, K. J., Lange, S., Freund, M., & Junghanß, C. (2012) · PubMed · Cited by 49
Phosphorylation‐dependent Akt–Inversin interaction at the basal body of primary cilia
Suizu, F., Hirata, N., Kimura, K., Edamura, T., Tanaka, T., Ishigaki, S., Donia, T., Noguchi, H., Iwanaga, T., & Noguchi, M. (2016) · The EMBO Journal · doi:10.15252/embj.201593003 · Cited by 51
Sarcopenia: Tilting the Balance of Protein Homeostasis
Tan, K. T., Ang, S. T., & Tsai, S. (2019) · PROTEOMICS · doi:10.1002/pmic.201800411 · Cited by 50
Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response
Vadysirisack, D. D., Baenke, F., Ory, B., Lei, K., & Ellisen, L. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05541-11 · Cited by 51
The rise and fall of insulin signaling in Alzheimer’s disease
Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48
Neuroprotective effects of the anticancer drug NVP-BEZ235 (dactolisib) on amyloid-β 1–42 induced neurotoxicity and memory impairment
Bellozi, P. M. Q., Lima, I. V. D. A., Doria, J. G., Vieira, É. L. M., Campos, A. C., Candelario‐Jalil, E., Reis, H. J., Teixeira, A. L., Ribeiro, F. M., & de Oliveira, A. C. P. (2016) · Scientific Reports · doi:10.1038/srep25226 · Cited by 47
Light-load resistance exercise increases muscle protein synthesis and hypertrophy signaling in elderly men
Agergaard, J., Bülow, J., Jensen, J. K., Reitelseder, S., Drummond, M. J., Schjerling, P., Scheike, T., Serena, A., & Holm, L. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00164.2016 · Cited by 47
The mTOR pathway: Implications for DNA replication
Lamm, N., Rogers, S., & Cesare, A. J. (2019) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2019.04.002 · Cited by 51
Foxo transcription factors in T cell biology and tumor immunity
Luo, C. T., & Li, M. O. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.04.006 · Cited by 46
Mutation of mouse Samd4 causes leanness, myopathy, uncoupled mitochondrial respiration, and dysregulated mTORC1 signaling
Chen, Z., Holland, W. L., Shelton, J. M., Ali, A., Zhan, X., Won, S., Tomisato, W., Liu, C., Li, X., Moresco, E. M. Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406511111 · Cited by 46
Pten deletion causes mTorc1-dependent ectopic neuroblast differentiation without causing uniform migration defects
Zhu, G. G., Chow, L. M. L., Bayazitov, I. T., Tong, Y., Gilbertson, R. J., Zakharenko, S. S., Solecki, D. J., & Baker, S. J. (2012) · Development · doi:10.1242/dev.083154 · Cited by 46
Proline-rich AKT substrate of 40-kDa (PRAS40) in the pathophysiology of cancer
Malla, R., Ashby, C. R., Narayanan, N. K., Narayanan, B. A., Faridi, J. S., & Tiwari, A. K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.041 · Cited by 46
Phospho-Form Specific Substrates of Protein Kinase B (AKT1)
McKenna, M., Balasuriya, N., Zhong, S., Li, S. S. ‐., & O’Donoghue, P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.619252 · Cited by 46
Translational control by oncogenic signaling pathways
Gao, B., & Roux, P. P. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.006 · Cited by 46
Cell-autonomous requirement for mammalian target of rapamycin (Mtor) in spermatogonial proliferation and differentiation in the mouse†
Serra, N. D., Velte, E. K., Niedenberger, B. A., Kirsanov, O., & Geyer, C. B. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox022 · Cited by 46
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Burris, H. A., Kurkjian, C. D., Hart, L., Pant, S., Murphy, P. B., Jones, S. F., Neuwirth, R. B., Patel, C. G., Zohren, F., & Infante, J. R. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3343-4 · Cited by 45
Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity
Yang, H., Wang, X., Zhang, Y., Liu, H., Liao, J., Shao, K., Chu, Y., & Liu, G. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24426 · Cited by 45
Regulation of Skeletal Muscle Protein Degradation and Synthesis by Oral Administration of Lysine in Rats
Sato, T., Ito, Y., & NAGASAWA, T. (2013) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.59.412 · Cited by 44
Effect of feeding a high-protein diet following an 18-hour period of feed withholding on mammalian target of rapamycin-dependent signaling in skeletal muscle of mature horses
Urschel, K. L., Escobar, J., McCutcheon, L. J., & Geor, R. J. (2011) · American Journal of Veterinary Research · doi:10.2460/ajvr.72.2.248 · Cited by 44
Amot and Yap1 regulate neuronal dendritic tree complexity and locomotor coordination in mice
Rojek, K. O., Krzemień, J., Doleżyczek, H., Boguszewski, P. M., Kaczmarek, L., Konopka, W., Rylski, M., Jaworski, J., Holmgren, L., & Prószyński, T. J. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000253 · Cited by 45
PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
Aguayo, F., Pérez-Domínguez, F., Osorio, J. C., Carolina Oliva, G., & Calaf, G. M. (2023) · Biology · doi:10.3390/biology12050672 · Cited by 43
Mis-regulation of Mammalian Target of Rapamycin (mTOR) Complexes Induced by Albuminuria in Proximal Tubules
Peruchetti, D. B., Cheng, J., Caruso‐Neves, C., & Guggino, W. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.549717 · Cited by 43
Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
Feng, W. W., & Kurokawa, M. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.100 · Cited by 44
Kinase mTOR: Regulation and role in maintenance of cellular homeostasis, tumor development, and aging
Parkhitko, A. A., Favorova, O. O., Khabibullin, D., Anisimov, V. N., & Henske, E. P. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914020023 · Cited by 44
KLF15 Is a Molecular Link between Endoplasmic Reticulum Stress and Insulin Resistance
Jung, D. Y., Chalasani, U., Pan, N., Friedline, R. H., Prosdocimo, D. A., Nam, M., Azuma, Y., Maganti, R. J., Yu, K. M., Velagapudi, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077851 · Cited by 43
Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imaging
Johnstone, M., Vasistha, N. A., Barbu, M. C., Dando, O., Burr, K., Christopher, E., Glen, S., Robert, C., Fetit, R., MacLeod, K. G., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0292-1 · Cited by 43
The roles of GTPase-activating proteins in regulated cell death and tumor immunity
He, H., Huang, J., Wu, S., Jiang, S., Liang, L., Liu, Y., Liu, W., Xie, L., Tao, Y., Jiang, Y., et al. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01184-1 · Cited by 43
Self-citation
Regulation of REDD1 by insulin‐like growth factor‐I in skeletal muscle and myotubes
Frost, R. A., Huber, D. S., Pruznak, A. M., & Lang, C. H. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22349 · Cited by 42
Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway
Bommer, U., Iadevaia, V., Chen, J., Knoch, B., Engel, M., & Proud, C. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.011 · Cited by 42
The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions
Alshehade, S. A., Alshawsh, M. A., Murugaiyah, V., Asif, M., Alshehade, O., Almoustafa, H. A., & Zarzour, R. H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120732 · Cited by 42
TOR complex 2 (TORC2) in Dictyostelium suppresses phagocytic nutrient capture independently of TORC1-mediated nutrient sensing
Rösel, D., Khurana, T., Majithia, A. R., Huang, X., Bhandari, R., & Kimmel, A. R. (2012) · Journal of Cell Science · doi:10.1242/jcs.077040 · Cited by 41
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1
Prabhakar, S., Cheah, P.-S., Zhang, X., Zinter, M., Gianatasio, M. T., Hudry, E., Bronson, R. T., Kwiatkowski, D. J., Stemmer-Rachamimov, A. O., Maguire, C. A., et al. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.08.003 · Cited by 40
Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy.
Jazirehi, A. R., Wenn, P. B., & Damavand, M. (2012) · Europe PMC (PubMed Central) · Cited by 40
Epidemiology, pathogenesis and diagnosis of lymphangioleiomyomatosis
Taveira‐DaSilva, A. M., & Moss, J. (2016) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2016.1148597 · Cited by 40
Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma
Wong, M. H., Xue, A., Baxter, R. C., Pavlakis, N., & Smith, R. C. (2016) · Neoplasia · doi:10.1016/j.neo.2016.06.001 · Cited by 40
Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex
Karalis, V., Caval-Holme, F., & Bateup, H. S. (2022) · Nature Communications · doi:10.1038/s41467-022-31961-6 · Cited by 40
Synaptic basis of social dysfunction: a focus on postsynaptic proteins linking group‐ I m G lu R s with AMPAR s and NMDAR s
O’Connor, E. C., Bariselli, S., & Bellone, C. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12510 · Cited by 40
Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin
Paul, D. S., Grevengoed, T. J., Pascual, F. L., Ellis, J. M., Willis, M. S., & Coleman, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.001 · Cited by 40
A review of brain insulin signaling in mood disorders: From biomarker to clinical target
Nguyen, T. T. L., Chan, L. C., Borreggine, K. L., Kale, R. P., Hu, C., & Tye, S. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.05.014 · Cited by 40
Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer
Li, X., Tong, L., Ding, J., & Meng, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.046 · Cited by 39
c-Jun Regulates Phosphoinositide-dependent Kinase 1 Transcription
Lopez‐Bergami, P., Kim, H., Dewing, A., Goydos, J. S., Aaronson, S. A., & Ronai, Z. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075630 · Cited by 39
Genome-scale RNAi on living-cell microarrays identifies novel regulators ofDrosophila melanogasterTORC1–S6K pathway signalingPreprint
Lindquist, R. A., Ottina, K. A., Wheeler, D. B., Hsu, P. P., Thoreen, C. C., Guertin, D. A., Ali, S. M., Sengupta, S., Shaul, Y. D., Lamprecht, M. R., et al. (2011) · Genome Research · doi:10.1101/gr.111492.110 · Cited by 38
Long-Term Everolimus Treatment in Individuals With Tuberous Sclerosis Complex: A Review of the Current Literature
Tran, L. H., & Zupanc, M. L. (2014) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2014.10.024 · Cited by 38
GSK-3 modulates cellular responses to a broad spectrum of kinase inhibitors
Thorne, C. A., Wichaidit, C., Coster, A. D., Posner, B. A., Wu, L. F., & Altschuler, S. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1690 · Cited by 40

Authors: Huang, J., & Manning, B. D.
Affiliations: Harvard University (US)
Corresponding author: Manning, Brendan D.
ORCID: Huang, Jingxiang
Manning, Brendan D.
Venue: Biochemical Society Transactions
Publisher: Portland Press Ltd.
Published: 2009-01-20
Volume: 37
Issue: 1
Pages: 217-222
ISSN: 0300-5127 (ISSN-L)
1470-8752
DOI: 10.1042/bst0370217
PMC: PMC2778026
OpenAlex: W2065322400
Cited by: 724
References: 35
Citations by year: 2026: 17 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 31 · 2021: 31 · 2020: 37 · 2019: 40 · 2018: 49 · 2017: 40 · 2016: 38 · 2015: 53 · 2014: 60 · 2013: 51 · 2012: 67
FWCI: 5.25
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Biochemical Society Transactions (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA122617, P01CA120964)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Akt, TSC1/TSC2 complex, tuberous sclerosis complex, mTORC1, mTORC2, PI3K signaling, Rheb, Akt phosphorylation, negative feedback regulation, growth factor signaling, tumor growth
MeSH terms: Tuberous Sclerosis Complex 2 Protein, Animals, Humans, Protein Kinases, Transcription Factors, Phosphatidylinositol 3-Kinases, Feedback, Physiological, Tumor Suppressor Proteins, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A complex interplay between Akt, TSC2 and the two mTOR complexes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks